Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2003
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003US20030186937 Produced from fermenting suspension of non-pathogenic saprophytic filamentous fungus; for use in food products to improve structure, texture, and stability; for prevention or treatment of immune disorders, tumors or microbial infections
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186912 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
10/02/2003US20030186906 Mixture comprising an inhibitor or suppresor of a gene and a molecule binding to an expression product of that gene
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186876 IL-6 antagonist peptides
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186857 Use of 3-position cyclosporin derivatives for hair growth
10/02/2003US20030186849 Modified peptides and their use for the treatment of autoimmune diseases
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186839 Medicinal compositions
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186384 Comprises enzyme complex formed from proteases for modulating apoptosis and treating tumor, allergenic, autoimmune diseases and inflammatory diseases
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186244 Using stored nucleotide sequence information to screen genome databases to detect restriction fragment length polymorphisms which are associated with genetic disorders
10/02/2003US20030186236 Diagnosis and prevention of infectibity of swine with porcine reproductive and respiratory syndrome virus; viricides; animal husbandry
10/02/2003US20030185900 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar (C12H22O11), and water.
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185825 Novel immunotoxins and methods of inducing immune tolerance
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185821 Antibodies to interleukin-4 receptors and uses thereof
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185806 Intact cells that express major histocompatibility antigens with a number of common allotypes from a given mammalian species.
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185793 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
10/02/2003US20030185765 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2484049A1 Imidazoquinoline adjuvants for vaccines
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2480039A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/02/2003CA2480034A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003CA2479908A1 Calcineurin activator
10/02/2003CA2479898A1 Novel .alpha.-amino-n-(diaminophosphinyl)lactam derivatives
10/02/2003CA2479887A1 Piperidine or 8-aza-bicyclo¬3.2.1|oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003CA2479881A1 Hif hydroxylase inhibitors
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2479686A1 A composition for treating pollinosis comprising an extract of sasa albo-marginata
10/02/2003CA2479288A1 Process for producing cytotoxic lymphocyte
10/02/2003CA2479277A1 Fused bicyclic pyrimidine derivatives
10/02/2003CA2479254A1 Preventive or therapeutic agent for renal disease
10/02/2003CA2479150A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2477651A1 Kinase inhibitors
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348714A1 Polypeptide useful as anti-allergic/antiasthmatic, methods for the preparation thereof and pharmaceutical compositions containing such polypeptide and their use
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348701A1 (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
10/01/2003EP1348434A1 Use of pyridyl amides as inhibitors of angiogenesis
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP1347974A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347965A1 New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1347787A1 Procedure and composition of treatment and/or care of the eye
10/01/2003EP1347775A2 Uses for polycationic compounds as vaccine adjuvants
10/01/2003EP1347773A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
10/01/2003EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347757A2 Method for detoxifying a carbohydrate containing solution
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1200435B1 Purine derivatives inhibitors of tyrosine protein kinase syk
10/01/2003EP1097712B1 Steroid-containing cataplasms and process for producing the same
10/01/2003EP1051190B1 Vaccine compositions for mucosal administration comprising chitosan and influenza antigen(s)
10/01/2003EP0998455B1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain
10/01/2003EP0946589B1 Inhibitors of peptide binding to mhc class ii proteins
10/01/2003EP0914043B1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003EP0772596B1 INDOLIZINE sPLA2 INHIBITORS
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446200A Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
10/01/2003CN1446082A ÔÇ£Slow releaseÔÇØ pharmaceutical compositions comprising lithium carbonate
1 ... 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 ... 1172